We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 10,946.00
Bid: 10,952.00
Ask: 10,954.00
Change: 32.00 (0.29%)
Spread: 2.00 (0.018%)
Open: 10,914.00
High: 10,954.00
Low: 10,764.00
Prev. Close: 10,914.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Japan's Suga urges citizens to have a quiet and distanced New Year

Fri, 25th Dec 2020 04:37

(Updates with reports on first cases of mutated coronavirus)

By Kiyoshi Takenaka and Tetsushi Kajimoto

TOKYO, Dec 25 (Reuters) - Japanese Prime Minister Yoshihide
Suga urged the nation on Friday to spend a quiet New Year period
without the usual social gatherings to prevent the spread of
COVID-19, which has been breaking infection records almost on a
daily basis.

Suga also announced a package of $2.6 billion for hospitals
treating COVID-19 patients which have come under strain due to
the rapid rise in cases across the northern island of Hokkaido
as well as large cities like Tokyo and Osaka.

"I want you to spend a quiet New Year," the premier told a
news conference in Tokyo with the government's leading
coronavirus expert Shigeru Omi.

"The infections aren't coming down and if we keep going like
this, we won't be able to avoid further spread of the virus."

The country confirmed its first cases of the new, faster-
spreading variant of the virus, in two citizens who had arrived
from the United Kingdom, domestic media reported late on Friday.

Japan has banned entry from United Kingdom, with the
exception of returning Japanese nationals and those with
residence permits.

Japan does not celebrate Christmas, but the New Year period
is an extended national holiday, with many people usually
travelling back to their hometowns and spending time with family
and friends.

Omi warned that it was critical that "all citizens move in
the same direction," to get a grip on the health crisis.

"If we don't bring infections down now, once they surge
again after the New Year period it won't be easy to change the
downward trend," he said. "It would take time, and would
probably be impossible to control over a period of weeks," he
said.

Omi said shared meals were a major cause of infections and
called on people to refrain from holding large gatherings and to
limit meals to four people one regularly ate with, or fewer.

While Japan has avoided the huge infection numbers seen in
other parts of the world, the number of new daily cases
surpassed 3,000 for the first time this month. Tokyo reported
884 infections on Friday, near Thursday's record 888.

HOSPITALS, VACCINES

Underscoring the strain on the hospitals, five national
groups of doctors and other medical workers made an emergency
request to Suga on Friday, asking for strong anti-pandemic
measures and support for the medical sector.

With hospitals equipped for treating COVID-19 filling up,
other hospitals are being forced to accept patients with the
disease, according to Tsuyoshi Masuda, president of the Japan
Federation of Democratic Medical Institutions.

"These small and medium-sized hospitals, which have been
supporting medical services in their respective regions, are
facing a crisis that is threatening their survival," Masuda told
reporters at a separate news conference on Friday.

He also warned that the risk of in-hospital infections was
high at institutions not specialized in dealing with infectious
diseases.

Japan, with a population of 126 million, has struck deals
to buy 290 million vaccine doses from Pfizer Inc,
AstraZeneca Plc and Moderna Inc, or enough for
145 million people.

A health ministry panel said that people aged 65 or older
should get priority for vaccination against COVID-19, as well as
frontline healthcare workers and people with underlying medical
conditions.

It specified chronic heart disease, chronic respiratory
disease and chronic kidney disease, among others, as underlying
conditions that should determine priority.

The panel's recommendations would mean 36 million elderly
people and 8.2 million people with medical conditions would be
the first to receive shots.
(Reporting by Kiyoshi Takenaka, Ju-min Park, Testsushi Kajimoto
and Antoni Slodkowski; Editing by Shri Navaratnam, Edmund
Klamann and William Mallard)

More News
18 Apr 2024 14:17

UK earnings, trading statements calendar - next 7 days

Friday 19 April 
888 Holdings PLCTrading Statement
Man Group PLCTrading Statement
Monday 22 April 
Brave Bison Group PLCFull Year Results
Elixirr International PLCFull Year Results
Frenkel Topping Group PLCFull Year Results
Mobico Group PLCFull Year Results
South32 LtdQ3 Results
Ten Lifestyle Group PLCHalf Year Results
Tuesday 23 April 
Alliance Pharma PLCFull Year Results
Alphawave IP Group PLCFull Year Results
Anglo American PLCTrading Statement
ASA International Group PLCFull Year Results
Associated British Foods PLCHalf Year Results
Eleco PLCFull Year Results
GB Group PLCTrading Statement
Jupiter Fund Management PLCTrading Statement
Maintel Holdings PLCFull Year Results
Property Franchise Group PLCFull Year Results
Taylor Wimpey PLCTrading Statement
tinyBuild IncFull Year Results
Trellus Health PLCFull Year Results
Wednesday 24 April 
1Spatial PLCFull Year Results
abrdn PLCTrading Statement
Ecora Resources PLCTrading Statement
Fresnillo PLCTrading Statement
Lloyds Banking Group PLCQ1 Results
Nichols PLCTrading Statement
PensionBee Group PLCFirst Quarter Results
PZ Cussons PLCTrading Statement
Reckitt Benckiser Group PLCTrading Statement
Sanderson Design Group PLCFull Year Results
Serica Energy PLCFull Year Results
Star Energy Group PLCFull Year Results
Tortilla Mexican Grill PLCFull Year Results
Tracsis PLCHalf Year Results
Warpaint London PLCFull Year Results
Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Hikma Pharmaceuticals PLCTrading Statement
Focusrite PLCHalf Year Results
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
16 Apr 2024 09:48

LONDON BROKER RATINGS: RBC raises Admiral; Barclays cuts Phoenix Group

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
16 Apr 2024 09:30

Boehringer replaces Bayer as Germany's largest drugmaker on Jardiance gains

INGELHEIM, Germany, April 16 (Reuters) - Boehringer Ingelheim on Tuesday overtook Bayer as Germany's largest drugmaker when the unlisted company reported a currency-adjusted gain in 2023 pharmaceutical sales of 10.3% to 20.8 billion euros ($22.11 billion).

Read more
16 Apr 2024 08:39

AstraZeneca's hails Imfinzi survival data on cancer form

(Alliance News) - AstraZeneca PLC on Tuesday said that its immunotherapy Imfinzi showed positive survival rate in people with advanced biliary tract cancer.

Read more
12 Apr 2024 12:55

EU regulator rules out link between weight-loss drugs and suicidal thoughts

April 12 (Reuters) - The European Union drug regulator found no evidence that a class of diabetes and weight-loss drugs such as Novo Nordisk's hugely popular Wegovy, are linked to suicidal thoughts, it said on Friday, ending a nine-month probe.

Read more
11 Apr 2024 18:51

AstraZeneca CEO could earn 19 million pounds as pay measure clears opposition

Policy approved with two-third of votes in favour

*

Read more
11 Apr 2024 17:13

FTSE 100 edges lower as financials drag

Lok'nStore surges to all-time high after buyout by Shurgard

*

Read more
11 Apr 2024 17:07

Banks weigh down Europe's STOXX 600 after ECB signals rate cuts

Outlook hike sends Ambu shares up

*

Read more
11 Apr 2024 15:56

London close: Stocks finish lower as ECB stands pat

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

Read more
11 Apr 2024 11:50

LONDON MARKET MIDDAY: Europe takes hit on nerves ahead of ECB decision

(Alliance News) - European equities sunk lower at midday on Thursday, with sentiment hurt by hotter-than-expected inflation from the US crushing hopes of interest rate cuts.

Read more
11 Apr 2024 08:56

TOP NEWS: Astra plans 7% dividend hike for 2024 after no rise in 2023

(Alliance News) - AstraZeneca PLC said it intends to raise its annualised dividend for 2024, citing confidence in its business performance and cash generation.

Read more
11 Apr 2024 08:54

LONDON MARKET OPEN: European markets mixed ahead of ECB decision

(Alliance News) - European equities lacked direction early Thursday morning, ahead of an interest rate decision from the European Central Bank this afternoon.

Read more
11 Apr 2024 07:49

LONDON BRIEFING: Astra promises dividend hike; Darktrace ups guidance

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye the latest interest rate decision from the European Central Bank, a day after a hotter-than-expected US inflation reading.

Read more
11 Apr 2024 07:20

AstraZeneca to hike 2024 dividend by 7%

(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.

Read more
8 Apr 2024 08:36

TOP NEWS: AstraZeneca hails neurological data for Ultomiris, Soliris

(Alliance News) - AstraZeneca PLC on Monday said long-term data in generalised myasthenia gravis will underscore the "vital role" of its Ultomiris and Soliris antibodies in the treatment landscape.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.